Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

James Miller

Concepts (325)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2637
2.440
 Why?
Smoking
20
2019
1472
1.200
 Why?
Bronchi
13
2018
267
1.120
 Why?
Carcinoma in Situ
5
2019
44
1.040
 Why?
Carcinoma, Squamous Cell
10
2018
641
0.720
 Why?
Carcinogens
4
2012
122
0.710
 Why?
Chemoprevention
3
2019
90
0.680
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
85
0.680
 Why?
Lung
16
2020
4109
0.560
 Why?
Carcinoma, Small Cell
7
2008
173
0.470
 Why?
Bronchoscopy
9
2019
227
0.460
 Why?
Urethane
3
2012
43
0.450
 Why?
Sputum
8
2019
308
0.440
 Why?
Bronchopulmonary Dysplasia
2
2019
410
0.440
 Why?
Pulmonary Alveoli
4
2012
383
0.430
 Why?
Iloprost
2
2012
44
0.430
 Why?
Hyperplasia
7
2011
174
0.430
 Why?
Precancerous Conditions
7
2020
166
0.410
 Why?
Neprilysin
3
1998
47
0.400
 Why?
Quinazolines
2
2012
266
0.370
 Why?
Biopsy
11
2019
1075
0.370
 Why?
Piperidines
2
2012
217
0.360
 Why?
Biomarkers, Tumor
7
2015
1313
0.360
 Why?
Antineoplastic Agents
4
2013
2194
0.350
 Why?
DNA Copy Number Variations
1
2011
183
0.330
 Why?
Genetic Markers
1
2011
331
0.330
 Why?
Bombesin
5
1998
10
0.330
 Why?
Amidohydrolases
3
1998
32
0.310
 Why?
Neurosecretory Systems
4
2004
31
0.300
 Why?
Isotretinoin
1
2009
26
0.300
 Why?
Ki-67 Antigen
3
2015
117
0.300
 Why?
Vasodilator Agents
1
2011
331
0.300
 Why?
Tocopherols
1
2009
30
0.290
 Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1180
0.290
 Why?
ErbB Receptors
1
2012
627
0.290
 Why?
Pulmonary Disease, Chronic Obstructive
4
2018
920
0.270
 Why?
Membrane Proteins
2
2008
1166
0.270
 Why?
Neovascularization, Pathologic
6
2015
286
0.270
 Why?
Mass Screening
3
2008
1347
0.260
 Why?
Respiratory Mucosa
2
2008
322
0.240
 Why?
Adenocarcinoma
6
2012
928
0.230
 Why?
Hypoxia
1
2012
1199
0.210
 Why?
Chromosomes, Human, Pair 3
4
2000
43
0.210
 Why?
Carcinoma, Bronchogenic
2
2002
20
0.200
 Why?
Chromosome Aberrations
4
2013
162
0.200
 Why?
Tomography, Spiral Computed
1
2002
30
0.190
 Why?
Middle Aged
28
2019
35875
0.180
 Why?
Aged
25
2019
25913
0.180
 Why?
Smokers
2
2019
137
0.170
 Why?
Humans
53
2020
144759
0.170
 Why?
Sensitivity and Specificity
10
2010
1985
0.170
 Why?
Placebos
2
2019
192
0.170
 Why?
Lung Diseases
5
2015
787
0.170
 Why?
Double-Blind Method
2
2019
2029
0.170
 Why?
Female
33
2019
78271
0.160
 Why?
Small Cell Lung Carcinoma
2
2012
119
0.160
 Why?
Tomography, X-Ray Computed
2
2020
2730
0.160
 Why?
Tumor Cells, Cultured
6
1998
919
0.150
 Why?
Neuropeptides
4
1998
77
0.150
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
121
0.150
 Why?
Male
30
2019
72315
0.150
 Why?
Remission Induction
1
2019
307
0.140
 Why?
In Situ Hybridization, Fluorescence
6
2010
322
0.140
 Why?
Blotting, Western
4
2012
1187
0.140
 Why?
Peptides
3
1996
995
0.140
 Why?
Genes, p53
1
1997
67
0.130
 Why?
Lung Diseases, Obstructive
1
1997
43
0.130
 Why?
Immunohistochemistry
8
2015
1716
0.130
 Why?
Point Mutation
1
1997
243
0.120
 Why?
Antibodies, Monoclonal
3
2010
1519
0.120
 Why?
Radiation Injuries, Experimental
1
1996
20
0.120
 Why?
Bradykinin
1
1996
48
0.120
 Why?
Proteomics
2
2015
1195
0.120
 Why?
Endopeptidases
1
1996
82
0.120
 Why?
Chromosomal Instability
2
2013
21
0.120
 Why?
Smoking Cessation
1
2019
439
0.110
 Why?
Multiple Pulmonary Nodules
1
2015
21
0.110
 Why?
Hyperoxia
1
1996
99
0.110
 Why?
Mice
10
2012
18339
0.110
 Why?
Animals
13
2013
38058
0.110
 Why?
Gene Expression
3
1998
1490
0.110
 Why?
Methylcholanthrene
2
2012
21
0.100
 Why?
Antigens
1
1996
347
0.100
 Why?
Butylated Hydroxytoluene
2
2012
36
0.100
 Why?
Mice, Transgenic
5
2009
2182
0.100
 Why?
Risk Factors
5
2019
10779
0.100
 Why?
Microarray Analysis
1
2013
117
0.100
 Why?
Stem Cells
1
2018
626
0.100
 Why?
Mutation
4
2000
4089
0.100
 Why?
Epithelium
4
2018
314
0.100
 Why?
Algorithms
3
2020
1837
0.100
 Why?
Intramolecular Oxidoreductases
2
2004
66
0.100
 Why?
Aged, 80 and over
8
2015
8265
0.100
 Why?
Risk
5
2012
911
0.100
 Why?
Carcinoma, Large Cell
1
2012
17
0.090
 Why?
Biological Products
1
1996
252
0.090
 Why?
Cytochrome P-450 Enzyme System
2
2004
162
0.090
 Why?
Epithelial Cells
3
2007
1125
0.090
 Why?
Receptors, Bombesin
1
2012
4
0.090
 Why?
Bronchoalveolar Lavage Fluid
3
2002
636
0.090
 Why?
Immunoenzyme Techniques
1
2012
200
0.090
 Why?
Cell Division
4
2000
766
0.090
 Why?
Volatile Organic Compounds
1
2012
60
0.090
 Why?
Case-Control Studies
8
2012
3604
0.090
 Why?
Dose-Response Relationship, Drug
2
2010
2027
0.080
 Why?
Chromosomes, Human, Pair 15
1
2011
50
0.080
 Why?
Sleep Apnea Syndromes
1
2012
97
0.080
 Why?
Eosinophilic Granuloma
1
1990
3
0.080
 Why?
Proto-Oncogene Proteins c-myc
1
2012
167
0.080
 Why?
Veterans
1
2002
1603
0.080
 Why?
Epithelial-Mesenchymal Transition
1
2012
219
0.080
 Why?
Antioxidants
2
2012
549
0.080
 Why?
Cell Line
5
2013
2882
0.080
 Why?
Plants, Toxic
1
1989
18
0.080
 Why?
Calcium
1
1996
1183
0.080
 Why?
Proteins
1
1996
1021
0.080
 Why?
Somatomedins
1
2009
28
0.080
 Why?
Genome-Wide Association Study
2
2013
1406
0.080
 Why?
Predictive Value of Tests
4
2009
2115
0.070
 Why?
Cell Proliferation
2
2018
2496
0.070
 Why?
Disease Progression
5
2018
2847
0.070
 Why?
Bronchial Neoplasms
1
2009
15
0.070
 Why?
Intracellular Signaling Peptides and Proteins
2
2011
459
0.070
 Why?
Chromosome Deletion
1
1989
124
0.070
 Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
 Why?
Adult
16
2018
40449
0.070
 Why?
Respiratory System
1
1989
149
0.070
 Why?
Airway Obstruction
3
2009
162
0.070
 Why?
GPI-Linked Proteins
1
2008
80
0.070
 Why?
Neoplasm Invasiveness
4
2015
508
0.070
 Why?
Polymorphism, Genetic
1
2011
612
0.070
 Why?
Fluorescence
3
2009
161
0.070
 Why?
Alkaline Phosphatase
1
2008
145
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Isoenzymes
1
2008
299
0.070
 Why?
Molecular Targeted Therapy
1
2010
432
0.060
 Why?
Cell Transformation, Neoplastic
1
2009
339
0.060
 Why?
Proto-Oncogene Proteins p21(ras)
1
2008
253
0.060
 Why?
Molecular Sequence Data
5
1998
2930
0.060
 Why?
Pulmonary Surfactants
2
1999
102
0.060
 Why?
Inflammation
1
2018
2878
0.060
 Why?
Exons
2
1998
358
0.060
 Why?
Fibroblasts
3
1998
1034
0.060
 Why?
MicroRNAs
1
2012
701
0.060
 Why?
Polymorphism, Single Nucleotide
1
2013
2145
0.060
 Why?
Follow-Up Studies
2
2015
5408
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
3
2005
851
0.060
 Why?
Early Detection of Cancer
1
2010
463
0.060
 Why?
ROC Curve
3
2015
614
0.060
 Why?
Adaptor Proteins, Signal Transducing
1
2008
427
0.060
 Why?
Recombinant Proteins
3
1998
1370
0.060
 Why?
Biomarkers
3
2010
4271
0.050
 Why?
Polymerase Chain Reaction
3
1998
1054
0.050
 Why?
RNA, Messenger
3
1998
2832
0.050
 Why?
Growth Hormone-Releasing Hormone
1
2004
19
0.050
 Why?
Acromegaly
1
2004
16
0.050
 Why?
Cytokines
1
2012
2061
0.050
 Why?
Protein Kinase Inhibitors
1
2010
969
0.050
 Why?
Adrenocorticotropic Hormone
1
2004
147
0.050
 Why?
Rats
4
2004
5597
0.050
 Why?
Base Sequence
3
1998
2190
0.050
 Why?
Smoke
1
2004
148
0.050
 Why?
Solitary Pulmonary Nodule
1
2002
23
0.050
 Why?
Metaplasia
2
2018
57
0.050
 Why?
Neoplasm Recurrence, Local
1
2009
1137
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
557
0.050
 Why?
Cross-Sectional Studies
2
2018
5868
0.040
 Why?
Sex Factors
1
2007
2112
0.040
 Why?
Hospitals, Veterans
1
2002
259
0.040
 Why?
Pulmonary Fibrosis
2
1998
395
0.040
 Why?
Radiation Dosage
1
2002
192
0.040
 Why?
Reproducibility of Results
1
2008
3409
0.040
 Why?
Gene Expression Regulation
1
1989
2608
0.040
 Why?
Amino Acid Sequence
3
1994
2155
0.040
 Why?
Cohort Studies
4
2015
5960
0.040
 Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
 Why?
Autocrine Communication
1
1998
38
0.040
 Why?
Desmoglein 3
1
2018
14
0.040
 Why?
gamma Catenin
1
2018
13
0.040
 Why?
Loss of Heterozygosity
2
2013
52
0.040
 Why?
DNA Primers
2
1998
512
0.040
 Why?
Light
1
2001
411
0.040
 Why?
Up-Regulation
2
2005
851
0.030
 Why?
Signal Transduction
3
1998
5226
0.030
 Why?
Bronchial Diseases
1
2018
38
0.030
 Why?
Paracrine Communication
1
1998
67
0.030
 Why?
Neoplasm Transplantation
1
1998
251
0.030
 Why?
Feasibility Studies
1
2002
1095
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
1998
40
0.030
 Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
14
0.030
 Why?
Time
1
2018
86
0.030
 Why?
Polymorphism, Single-Stranded Conformational
1
1997
26
0.030
 Why?
Cell Cycle Checkpoints
1
2018
99
0.030
 Why?
Genes, Tumor Suppressor
1
1998
83
0.030
 Why?
Gene Expression Profiling
1
2005
1782
0.030
 Why?
Alveolitis, Extrinsic Allergic
1
1998
93
0.030
 Why?
Polymorphism, Restriction Fragment Length
1
1997
64
0.030
 Why?
Likelihood Functions
1
1998
143
0.030
 Why?
DNA, Complementary
1
1998
276
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
1998
269
0.030
 Why?
Codon
1
1997
94
0.030
 Why?
Neoplasm Staging
2
2012
1462
0.030
 Why?
Introns
1
1998
254
0.030
 Why?
Mice, Nude
1
1998
682
0.030
 Why?
Membrane Glycoproteins
1
1999
496
0.030
 Why?
United States
2
2011
15966
0.030
 Why?
Enzyme Activation
1
1998
766
0.030
 Why?
Immunoassay
2
1998
109
0.030
 Why?
Incidence
3
2010
2879
0.030
 Why?
Treatment Outcome
1
2011
11679
0.030
 Why?
RNA, Neoplasm
1
1996
86
0.030
 Why?
Glycopeptides
1
1996
44
0.030
 Why?
Mesothelioma
1
1996
48
0.030
 Why?
Image Processing, Computer-Assisted
1
2020
780
0.030
 Why?
Proto-Oncogene Proteins
1
2018
623
0.030
 Why?
Sequence Analysis, DNA
1
1998
824
0.030
 Why?
Antigens, CD
2
1998
555
0.030
 Why?
Receptors, Peptide
1
1994
18
0.030
 Why?
Cell Cycle Proteins
1
2018
628
0.030
 Why?
Machine Learning
1
2020
585
0.030
 Why?
Databases, Factual
1
2020
1486
0.030
 Why?
Rh-Hr Blood-Group System
1
1994
14
0.030
 Why?
Myelin Sheath
1
1996
168
0.030
 Why?
Erythrocyte Membrane
1
1994
54
0.030
 Why?
Blotting, Southern
1
1993
85
0.030
 Why?
Blotting, Northern
1
1993
204
0.020
 Why?
Neoplasm Metastasis
1
1996
688
0.020
 Why?
Prospective Studies
3
2012
7990
0.020
 Why?
DNA, Neoplasm
1
1993
163
0.020
 Why?
Cells, Cultured
2
2007
4154
0.020
 Why?
Solid Phase Microextraction
1
2012
7
0.020
 Why?
Endoscopy
1
2015
316
0.020
 Why?
Dinoprostone
2
2004
178
0.020
 Why?
Fluorescent Antibody Technique
1
1993
370
0.020
 Why?
Cloning, Molecular
1
1993
540
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
131
0.020
 Why?
Breath Tests
1
2012
79
0.020
 Why?
Enzyme Inhibitors
1
1996
824
0.020
 Why?
Colorado
1
2002
4564
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1455
0.020
 Why?
Liver Neoplasms
1
1998
780
0.020
 Why?
Iceland
1
2011
11
0.020
 Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
14
0.020
 Why?
Spain
1
2011
48
0.020
 Why?
Netherlands
1
2011
82
0.020
 Why?
Respiratory Tract Diseases
1
1992
175
0.020
 Why?
Cattle
1
1993
1000
0.020
 Why?
Rats, Sprague-Dawley
1
1996
2527
0.020
 Why?
Administration, Oral
1
2012
847
0.020
 Why?
Meta-Analysis as Topic
1
2011
174
0.020
 Why?
Severity of Illness Index
1
2018
2925
0.020
 Why?
Carrier Proteins
1
1994
737
0.020
 Why?
Receptor, IGF Type 1
1
2009
64
0.020
 Why?
Flow Cytometry
1
1993
1173
0.020
 Why?
Area Under Curve
1
2010
330
0.020
 Why?
Prognosis
2
2012
4282
0.020
 Why?
International Agencies
1
2009
30
0.020
 Why?
Cystic Fibrosis
1
1998
1158
0.020
 Why?
Erythrocytes
1
1994
757
0.020
 Why?
Chromatography, High Pressure Liquid
1
1989
594
0.020
 Why?
Mass Spectrometry
1
2010
750
0.020
 Why?
Genome, Human
1
2009
422
0.020
 Why?
Pilot Projects
1
2012
1886
0.020
 Why?
Models, Statistical
1
2010
681
0.020
 Why?
Genotype
1
2011
1833
0.010
 Why?
Amino Acids
1
1989
521
0.010
 Why?
Disease Models, Animal
1
1996
4557
0.010
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.010
 Why?
Epoprostenol
1
2004
131
0.010
 Why?
Genomics
1
2009
834
0.010
 Why?
Bronchiolitis
1
2004
87
0.010
 Why?
Autoantibodies
1
2010
1501
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
983
0.010
 Why?
Fruit
1
2003
152
0.010
 Why?
Vegetables
1
2003
170
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2004
758
0.010
 Why?
Pituitary Neoplasms
1
2004
190
0.010
 Why?
Respiratory Function Tests
1
2004
547
0.010
 Why?
Genetic Predisposition to Disease
1
2011
2363
0.010
 Why?
Adenoma
1
2004
218
0.010
 Why?
Regression Analysis
1
2003
1003
0.010
 Why?
Single-Blind Method
1
2001
312
0.010
 Why?
Weight Gain
1
2004
556
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
49
0.010
 Why?
Carcinoma
1
2001
228
0.010
 Why?
Bronchoscopes
1
1998
3
0.010
 Why?
RNA
1
2005
940
0.010
 Why?
Endoglin
1
1998
19
0.010
 Why?
Random Allocation
1
1998
363
0.010
 Why?
Genetic Linkage
1
1998
273
0.010
 Why?
Reference Values
1
1998
797
0.010
 Why?
Retrospective Studies
1
2015
17066
0.010
 Why?
Comorbidity
1
2001
1658
0.010
 Why?
Linear Models
1
1998
854
0.010
 Why?
Tumor Suppressor Protein p53
1
2000
529
0.010
 Why?
Analysis of Variance
1
1998
1306
0.010
 Why?
Longitudinal Studies
1
2003
2947
0.010
 Why?
Diet
1
2003
1273
0.010
 Why?
Receptors, Cell Surface
1
1998
377
0.010
 Why?
Alleles
1
1998
879
0.010
 Why?
Risk Assessment
1
2004
3671
0.010
 Why?
Chromatography, Affinity
1
1994
85
0.010
 Why?
Infant, Premature
1
1998
611
0.010
 Why?
Young Adult
1
2011
14105
0.010
 Why?
CD47 Antigen
1
1994
42
0.010
 Why?
Genes
1
1994
226
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1994
331
0.010
 Why?
Endothelium, Vascular
1
2000
965
0.010
 Why?
Moths
1
1994
52
0.010
 Why?
Cytoplasm
1
1994
269
0.010
 Why?
Carcinoid Tumor
1
1992
21
0.010
 Why?
Chromosome Mapping
1
1994
510
0.010
 Why?
Lymphocytes
1
1994
382
0.010
 Why?
Transfection
1
1994
940
0.010
 Why?
Adolescent
1
2011
22428
0.010
 Why?
Mice, Inbred BALB C
1
1994
1253
0.010
 Why?
Dyspnea
1
1992
251
0.010
 Why?
Binding Sites
1
1994
1329
0.010
 Why?
Fibrosis
1
1992
548
0.000
 Why?
Phenotype
1
1998
3162
0.000
 Why?
Aging
1
1998
1966
0.000
 Why?
Infant, Newborn
1
1998
6429
0.000
 Why?
Infant
1
1998
10034
0.000
 Why?
Child, Preschool
1
1998
11787
0.000
 Why?
Child
1
1998
22633
0.000
 Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (325) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)